Efficacy of 6-monthly HIV prevention jab confirmed in second major study

In June, we heard what could be this year’s biggest HIV breakthrough: a twice-yearly injection can prevent HIV infection. Findings from a second large study of the jab has now confirmed that it works. Elri Voigt goes over the new findings and unpacks the licenses that are expected to facilitate the availability of generic versions of the jab in over a hundred countries, including South Africa.

Read More

What can SA do to prepare for snake antivenom shortages?

Some researchers argue that South Africa should look into using “expired” doses of antivenom if the country once again struggles to make enough of the treatment – something which happened in 2023. In part 2 of a Spotlight special series on snake antivenom, Jesse Copelyn outlines the case for extending the shelf-life and goes over some exciting, but very early, research on a new form of antivenom.

Read More

In-depth: Codeine regulation – a tussle between pain relief and addiction

Whether a pharmacist suggests it for treating headaches or whether a doctor prescribes it for managing post-surgical pain, chances are good that at some point you’ve taken a pain pill containing the opioid codeine. But since codeine can be addictive and withdrawal symptoms severe, regulation of the drug in South Africa has turned into a headache. Elri Voigt takes an in-depth look at the complexities of codeine regulation.

Read More